The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Efficacy and Safety of Paricalcitol in the Reduction of Secondary Hyperparathyroidism After Kidney Transplantation.
Official Title: Efficacy and Safety of Paricalcitol in the Reduction of Secondary Hyperparathyroidism After Renal Transplantation.
Study ID: NCT01939977
Brief Summary: To demonstrate the superiority of paricalcitol treatment at early renal post-transplantation (M6) in the control of iPTH (Intact parathyroid hormone) compared to the use of vitamin D nutritional supplements (calcifediol) in patients with renal transplantation.
Detailed Description: The purpose of this study is to demonstrate the superiority of paricalcitol treatment at early renal post-transplantation (M6) in the control of iPTH (Intact parathyroid hormone) compared to the use of vitamin D nutritional supplements (calcifediol) in patients with renal transplantation.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Hospital Universitari Germans Trias I Pujol de Badalona, Badalona, Barcelona, Spain
Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain
Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain
Hospital Del Mar, Barcelona, , Spain
Fundació Puigvert-Iuna, Barcelona, , Spain
Hospital Universitari Vall D'Hebron, Barcelona, , Spain
Hospital Puerta Del Mar, Cádiz, , Spain
Hospital Reina Sofía, Córdoba, , Spain
Complexo Hospitalario Universitario A Coruna, La Coruna, , Spain
Complejo Hospitalario Universitario de Canarias, Las Palmas De Gran Canaria, , Spain
Hospital Ramón Y Cajal, Madrid, , Spain
Hospital Universitario 12 de Octubre, Madrid, , Spain
Complejo Hospitalario Regional de Málaga, Málaga, , Spain
Hospital Virgen Del Rocío, Sevilla, , Spain
Hospital Universitari I Politècnic La Fe, Valencia, , Spain
Hospital Universitario Miguel Servet, Zaragoza, , Spain
Name: Josep M Cruzado, Dr
Affiliation: Fundación SENEFRO - Hospital Universitario de Bellvitge - Barcelona.
Role: PRINCIPAL_INVESTIGATOR